Good Samaritan Hospital Medical Center, New York
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Good Samaritan Hospital Medical Center, New York sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).
Good Samaritan Hospital Medical Center, New York: 3 sponsored US clinical trials, 1 recruiting.
Good Samaritan Hospital Medical Center, New York sponsors 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 1 completed. The most-studied condition in this pipeline is Metastasis, with 1 trials.
Upper-quartile sponsor footprint
Good Samaritan Hospital Medical Center, New York sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
3 total, page 1 of 1
Clinical Nurse Specialist Led Early Palliative Survivorship Care for Patients With Advanced Cancer
NCT05947695
Long Term Follow UP After Pediatric Single Site Robotic Cholecystectomy
NCT07383961
Feasibility Trial of Darwin OncoTreat and OncoTarget Precision Medicine Testing
NCT06842030
Therapeutic Areas
What is open in the Good Samaritan Hospital Medical Center, New York pipeline
1 recruiting of 3 indexed (33% open); 1 completed (33%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Metastasis (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Good Samaritan Hospital Medical Center, New York: open-pipeline peers nationwide
Peers matched on 3 registered trials and 33% open enrollment, not the therapeutic-area sidebar.
Good Samaritan Hospital Medical Center, New York sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 3 trials (± recruiting share)
- 10xBio · 3 trials · 0% recruiting
- 22nd Century Group · 3 trials · 0% recruiting
- AA Secord · 3 trials · 0% recruiting
- AAADRS Clinical Research Center · 3 trials · 0% recruiting
Sponsors near 33% open enrollment (± trial volume)
- Aadi Bioscience · 33% recruiting · 9 trials
- Aaron Cook · 33% recruiting · 3 trials
- Abivax S.A. · 33% recruiting · 6 trials
- Actuated Medical · 33% recruiting · 3 trials
Related
What to do with this Good Samaritan Hospital Medical Center, New York page
3 registered trials is a research-attention snapshot, not an endorsement of Good Samaritan Hospital Medical Center, New York or any single study.
- 1 of Good Samaritan Hospital Medical Center, New York's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Metastasis is the condition Good Samaritan Hospital Medical Center, New York studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Metastasis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Good Samaritan Hospital Medical Center, New York pipeline card: 3 registered trials from official public datasets.Report a data error.